Get the Stockscreener App
0.8302
2.33%
-0.0198
After Hours:
.80
-0.0302
-3.64%
Intercure Ltd stock is traded at $0.8302, with a volume of 23,573.
It is down -2.33% in the last 24 hours and down -10.92% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$0.85
Open:
$0.83077
24h Volume:
23,573
Relative Volume:
0.27
Market Cap:
$45.40M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
6.2942
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
-6.72%
1M Performance:
-10.92%
6M Performance:
-49.99%
1Y Performance:
-49.07%
1-Day Range:
$0.7951
$0.871
1-Week Range:
$0.7612
$0.89
52-Week Range:
$0.68
$1.7698
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.8302 | 46.48M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.61 | 58.92B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.95 | 54.31B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.44 | 49.34B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.62 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
535.10 | 20.38B | 3.13B | 1.27B | 1.12B | 26.39 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
Earnings Recap: Will RDACU outperform its industry peersJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
What’s the fair value of InterCure Ltd. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
Bearish Setup: Is InterCure Ltd being accumulated by smart money2025 Market Overview & Safe Capital Preservation Plans - baoquankhu1.vn
InterCure reports 11% revenue growth for 2025, enters German market By Investing.com - Investing.com Nigeria
InterCure reports 11% revenue growth for 2025, enters German market - Investing.com
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans - TipRanks
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - markets.businessinsider.com
Cannabis grower InterCure rebounds from Gaza war damage to NIS 265M sales - Stock Titan
Risk Check: Why is InterCure Ltd stock going up2025 Top Decliners & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Why is InterCure Ltd. stock going upQuarterly Profit Report & Technical Buy Zone Confirmations - mfd.ru
What are InterCure Ltd.’s growth leversJuly 2025 Sentiment & Safe Entry Trade Signal Reports - mfd.ru
Hedge Fund Bets: Will InterCure Ltd. benefit from green energy policies2025 Volatility Report & Low Risk Investment Opportunities - baoquankhu1.vn
InterCure faces NIS 27 million exposure as key cannabis partner Bazelet enters restructuring - MSN
Head-To-Head Contrast: InterCure (NASDAQ:INCR) versus CompuMed (OTCMKTS:CMPD) - Defense World
Quarterly Trades: Is InterCure Ltd exposed to currency risks2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Does InterCure Ltd. stock benefit from AI growthWeekly Profit Report & Risk Controlled Daily Trade Plans - mfd.ru
RSI Check: Is InterCure Ltd undervalued by DCF analysisMarket Movers & Low Risk Entry Point Tips - baoquankhu1.vn
Surprises Report: Is InterCure Ltd a potential multi baggerWeekly Loss Report & Daily Profit Maximizing Tips - baoquankhu1.vn
Why Investors Shouldn't Be Surprised By InterCure Ltd.'s (TLV:INCR) 29% Share Price Plunge - simplywall.st
Will InterCure Ltd. stock gain from strong economyEarnings Recap Summary & Community Trade Idea Sharing Platform - Улправда
Published on: 2026-01-12 07:36:04 - ulpravda.ru
Can InterCure Ltd. stock attract ESG capital inflows2025 Buyback Activity & AI Enhanced Trade Execution Alerts - Улправда
Will InterCure Ltd. stock attract ESG investorsJuly 2025 Gainers & Smart Swing Trading Alerts - Улправда
Top Cannabis Stocks To Watch Today – January 1st - Defense World
Wall Street Recap: How InterCure Ltd stock compares to market leadersJuly 2025 Technicals & Stepwise Swing Trade Plans - moha.gov.vn
InterCure (NASDAQ:INCR) Shares Down 6.6% – Should You Sell? - Defense World
InterCure Shareholders Approve All Proposals at 2025 Annual Meeting - TipRanks
InterCure shareholders approve all proposals at 2025 annual meeting - MSN
We Discuss Why InterCure Ltd.'s (TLV:INCR) CEO Compensation May Be Closely Reviewed - simplywall.st
Why InterCure Ltd. stock could see breakout soonInterest Rate Changes & Zero-Cost Stock Research by Professionals - bollywoodhelpline.com
Critical Contrast: InterCure (NASDAQ:INCR) & Varex Imaging (NASDAQ:VREX) - Defense World
Is InterCure Ltd. stock a buy for dividend growthJuly 2025 Volume & Verified Stock Trade Ideas - Улправда
How InterCure Ltd. stock compares to market leaders2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Will InterCure Ltd. stock gain from lower inflationDollar Strength & Weekly Market Pulse Updates - DonanımHaber
What valuation multiples suggest for InterCure Ltd. stockEarnings Growth Report & Technical Confirmation Alerts - ulpravda.ru
InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court - marketscreener.com
InterCure Ltd On Dec 15, Became Aware That Bazelet Group Of Companies Has Initiated Restructuring Proceedings Before The Israeli District Court - TradingView — Track All Markets
InterCure Faces NIS 27 Million Exposure as Key Cannabis Partner Bazelet Enters Restructuring - TipRanks
[6-K] Intercure Ltd. Current Report (Foreign Issuer) | INCR SEC FilingForm 6-K - Stock Titan
InterCure (TLV:INCR) shareholders are up 16% this past week, but still in the red over the last five years - simplywall.st
InterCure May Be Uniquely Positioned as Trump’s Cannabis Rescheduling Returns to Headlines (NASDAQ: INCR) - TradingView — Track All Markets
Head to Head Comparison: InterCure (NASDAQ:INCR) and Jushi (OTCMKTS:JUSHF) - Defense World
How interest rate cuts could boost InterCure Ltd. stockJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How resilient is InterCure Ltd. stock in market downturnsGold Moves & Expert Approved Trade Ideas - Newser
Is InterCure Ltd. stock a buy before product launchesJuly 2025 Decliners & Weekly Top Performers Watchlists - Newser
Will InterCure Ltd. stock see PE expansionGold Moves & Low Drawdown Trading Strategies - Newser
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):